RASAL1 and thyroid cancer, nonmedullary, 2: Consistent with the present study, we previously found hardly mutations in RASAL1 in papillary thyroid cancer (PTC), but found inactivating RASAL1 mutations in FTC and ATC although RASAL1 hypermethylation was common in PTC [8].